Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysis

por Ivama-Brummell, Adriana M., Marciniuk, Fernanda L., Wagner, Anita K., Osorio-de-Castro, Claudia G.S., Vogler, Sabine, Mossialos, Elias, Tavares-de-Andrade, Carla L., Naci, Huseyin
Publicado 2023